Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 8, 2016 | Xeris Biopharma | $41.0M Series C | Rob Faulkner | Deerfield Management, The McNair Group |
| Jun 1, 2015 | Cogent Biosciences | $65.0M Series B | Liam Ratcliffe | Access Biotechnology, Atlas Venture, Brandon Capital Partners, Josh Resnick, Brace Pharma Capital, Cowen Private Investments, F-Prime Capital, Jennison Associates, Novo Holdings, Sanofi Ventures, Seattle Genetics, Sectoral Asset Management, Wellington Management |